Journal articles
Tansley SL;  Betteridge ZE;  Simou S;  Jacques TS;  Pilkington C;  Wood M;  Warrier K;  Wedderburn LR;  McHugh NJ;  Armon K;  Ellis-Gage J;  Roper H;  Briggs V;  Watts J;  McCann L;  Roberts I;  Baildam E;  Hanna L;  Lloyd O;  Wadeson S;  Riley P;  McGovern A;  Ryder C;  Scott J;  Thomas B;  Southwood T;  Al-Abadi E;  Wyatt S;  Jackson G;  Amin T;  VanRooyen V;  Burton D;  Davidson J;  Gardner-Medwin J;  Martin N;  Ferguson S;  Waxman L;  Browne M;  Friswell M;  Foster H;  Swift A;  Jandial S;  Stevenson V;  Wade D;  Sen E;  Smith E;  Qiao L;  Watson S;  Duong C;  Venning H;  Satyapal R;  Stretton E;  Jordan M;  Mosley E;  Frost A;  Crate L;  Stafford S;  Hasson N;  Maillard S;  Halkon E;  Brown V;  Juggins A;  Smith S;  Lunt S;  Enayat E;  Varsani H;  Kassoumeri L;  Beard L;  Arnold K;  Glackin Y;  Simou S;  Almeida B;  Nistala K;  Marques R;  Yasin S;  Deakin C;  Dowle S;  Papadopoulou C;  Murray K;  Ioannou J;  Suffield L;  Al-Obaidi M;  Lee H;  Leach S;  Smith H;  McMahon AM;  Chisem H;  Kingshott R;  Wilkinson N;  Inness E;  Kendall E;  Mayers D;  Etherton R;  Bailey K;  Clinch J;  Fineman N;  Pluess-Hall H;  Vallance L;  Akeroyd L;  Leahy A, 2017, 'Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients', Journal of Rheumatology, 44,  pp. 488 - 492, http://dx.doi.org/10.3899/jrheum.160871
Yasin SA;  Schutz PW;  Deakin CT;  Sag E;  Varsani H;  Simou S;  Tansley S;  McHugh N;  Holton JL;  Wedderburn LR;  Jacques TS, 2017, 'Biopsy pathology in a large cohort of juvenile dermatomyositis is heterogeneous and, for the most part, independent of autoantibody phenotype', Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 44,  pp. S6 - S6, http://dx.doi.org/10.1017/cjn.2017.17
Tansley SL;  Shaddick G;  Simou S;  Betteridge Z;  Deakin C;  Soponkanaporn S;  Gunawardena H;  Wedderburn L;  McHugh N, 2017, 'CONNECTIVE TISSUE DISORDERS AND VASCULITIS ORAL ABSTRACTSO13. AUTOANTIBODY SUBTYPE IN PATIENTS WITH JUVENILE-ONSET MYOSITIS INFLUENCES TREATMENT RECEIVED', Rheumatology, 56, http://dx.doi.org/10.1093/rheumatology/kex061.013
Deakin CT;  Yasin SA;  Simou S;  Arnold KA;  Tansley SL;  Betteridge ZE;  McHugh NJ;  Varsani H;  Holton JL;  Jacques TS;  Pilkington CA;  Nistala K;  Wedderburn LR;  Armon K;  Ellis-Gage J;  Roper H;  Briggs V;  Watts J;  McCann L;  Roberts I;  Baildam E;  Hanna L;  Lloyd O;  Wadeson S;  Riley P;  McGovern A;  Ryder C;  Scott J;  Thomas B;  Southwood T;  Al-Abadi E;  Wyatt S;  Jackson G;  Amin T;  Wood M;  VanRooyen V;  Burton D;  Davidson J;  Gardner-Medwin J;  Martin N;  Ferguson S;  Waxman L;  Browne M;  Friswell M;  Swift A;  Jandial S;  Stevenson V;  Wade D;  Sen E;  Smith E;  Qiao L;  Watson S;  Duong C;  Venning H;  Satyapal R;  Stretton E;  Jordan M;  Mosley E;  Frost A;  Crate L;  Warrier K;  Stafford S;  Hasson N;  Maillard S;  Halkon E;  Brown V;  Juggins A;  Smith S;  Lunt S;  Enayat E;  Kassoumeri L;  Beard L;  Glackin Y;  Almeida B;  Marques R;  Dowle S;  Papadopoulou C;  Murray K;  Ioannou J;  Suffield L;  Al-Obaidi M;  Lee H;  Leach S;  Smith H;  McMahon AM;  Chisem H;  Kingshott R;  Wilkinson N;  Inness E;  Kendall E;  Mayers D;  Etherton R;  Bailey K;  Clinch J;  Fineman N;  Pluess-Hall H;  Vallance L;  Akeroyd L;  Leahy A;  Collier A, 2016, 'Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis', Arthritis and Rheumatology, 68,  pp. 2806 - 2816, http://dx.doi.org/10.1002/art.39753
Campanilho-Marques R;  Almeida B;  Deakin C;  Arnold K;  Gallot N;  de Iorio M;  Nistala K;  Pilkington CA;  Wedderburn LR;  Armon K;  Ellis-Gage J;  Roper H;  Briggs V;  Watts J;  McCann L;  Roberts I;  Baildam E;  Hanna L;  Lloyd O;  Riley P;  McGovern A;  Ryder C;  Scott J;  Thomas B;  Southwood T;  Al-Abadi E;  Wyatt S;  Jackson G;  Amin T;  Wood M;  VanRooyen V;  Burton D;  Davidson J;  Gardner-Medwin J;  Martin N;  Ferguson S;  Waxman L;  Browne M;  Friswell M;  Foster H;  Swift A;  Jandial S;  Stevenson V;  Wade D;  Sen E;  Smith E;  Qiao L;  Watson S;  Venning H;  Satyapal R;  Stretton E;  Jordan M;  Mosley E;  Frost A;  Crate L;  Warrier K;  Hasson N;  Maillard S;  Halkon E;  Brown V;  Juggins A;  Smith S;  Lunt S;  Enayat E;  Varsani H;  Kassoumeri L;  Beard L;  Glackin Y;  Simou S;  Murray K;  Ioannou J;  Suffield L;  Al-Obaidi M;  Lee H;  Leach S;  Smith H;  Wilkinson N;  Inness E;  Kendall E;  Mayers D;  Clinch J;  Pluess-Hall H, 2016, 'Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis', Arthritis Care and Research, 68,  pp. 1514 - 1521, http://dx.doi.org/10.1002/acr.22867
Deakin CT;  Deakin JJ;  Ginn SL;  Young P;  Humphreys D;  Suter CM;  Alexander IE;  Hallwirth CV, 2014, 'Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence', NUCLEIC ACIDS RESEARCH, 42, http://dx.doi.org/10.1093/nar/gku607
Deakin CT;  Alexander IE;  Hooker CA;  Kerridge IH, 2013, 'Gene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trials', Molecular Therapy, 21,  pp. 806 - 815, http://dx.doi.org/10.1038/mt.2012.230
Deakin CT;  Alexander IE;  Kerridge I, 2010, 'The ethics of gene therapy: Balancing the risks', Current Opinion in Molecular Therapeutics, 12,  pp. 578 - 585
Bennett B;  Deakin C, 2009, 'Registration of clinical trials: challenges for global regulation.', Journal of Law and Medicine, 17,  pp. 82 - 94
Deakin CT;  Alexander IE;  Kerridge I, 2009, 'Accepting risk in clinical research: Is the gene therapy field becoming too risk-averse?', Molecular Therapy, 17,  pp. 1842 - 1848, http://dx.doi.org/10.1038/mt.2009.223
Deakin C, 2008, 'Resolving the regulatory conflict: Lessons for Australia from the European experience of regulating the release of genetically modified organisms into the environment', Environmental and Planning Law Journal, 25,  pp. 22 - 48
Smyth CM;  Ginn SL;  Deakin CT;  Logan GJ;  Alexander IE, 2007, 'Limiting γc expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors', Blood, 110,  pp. 91 - 98, http://dx.doi.org/10.1182/blood-2006-11-055442
Back to profile page